These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1823754)

  • 1. [Identification of viable myocardium: current goal in ischemic heart disease with ventricular dysfunction].
    Marin-Neto JA; Bonow RO
    Arq Bras Cardiol; 1991 Jul; 57(1):1-3. PubMed ID: 1823754
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography for the assessment of myocardial viability.
    Schelbert HR
    Circulation; 1991 Sep; 84(3 Suppl):I122-31. PubMed ID: 1884478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of thallium-201 myocardial perfusion imaging in three primary patient populations.
    Brown KA
    Am J Cardiol; 1992 Nov; 70(14):23E-29E. PubMed ID: 1442568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"].
    Nienaber CA; Carnarius H
    Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT].
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Yonekura Y; Yamashita K; Konishi J; Ban T; Mikawa H
    J Cardiol; 1992; 22(1):21-6. PubMed ID: 1307567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The continuing story of (201)Tl reverse redistribution: reverse redistribution is still alive, but is the myocardium still viable?
    Faraggi M
    J Nucl Med; 2002 May; 43(5):628-31. PubMed ID: 11994525
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of viable myocardium.
    Bonow RO
    Circulation; 1996 Dec; 94(11):2674-80. PubMed ID: 8941085
    [No Abstract]   [Full Text] [Related]  

  • 9. The character of transient myocardial ischemia: clinical studies and progress using positron emission tomography.
    Selwyn AP; Shea M; Deanfield J; Wilson R; DeLandsheere C; Jones T
    Int J Card Imaging; 1985; 1(1):61-72. PubMed ID: 3916484
    [No Abstract]   [Full Text] [Related]  

  • 10. Thallium scintigraphy for diagnosis and risk assessment of coronary artery disease.
    Lancet; 1991 Sep; 338(8770):786-8. PubMed ID: 1681165
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myocardial positron computed tomography using N-13 ammonia for evaluating coronary artery disease: comparison with thallium-201 emission computed tomography].
    Tamaki N; Yonekura Y; Kodama S; Senda M; Saji H; Torizuka K; Kambara H; Kawai C; Konishi Y; Ban T
    J Cardiogr; 1985 Sep; 15(3):553-65. PubMed ID: 3879760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into coronary artery disease gained from metabolic imaging.
    Schelbert HR; Buxton D
    Circulation; 1988 Sep; 78(3):496-505. PubMed ID: 3044639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.
    Dilsizian V; Rocco TP; Freedman NM; Leon MB; Bonow RO
    N Engl J Med; 1990 Jul; 323(3):141-6. PubMed ID: 2362606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radionuclide imaging of coronary diseases].
    Saito T; Himi H; Inagaki Y
    Nihon Naika Gakkai Zasshi; 1990 Nov; 79(11):1513-7. PubMed ID: 2177760
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial perfusion imaging in ischemic heart disease.
    Ashburn WL; Tubau J
    Radiol Clin North Am; 1980 Dec; 18(3):467-86. PubMed ID: 7005933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perfusion scintigraphy of the heart].
    van Vlies B; van Royen EA
    Ned Tijdschr Geneeskd; 1991 Sep; 135(37):1681-6. PubMed ID: 1922510
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial perfusion studies: lessons from a decade of clinical use.
    Strauss HW; Boucher CA
    Radiology; 1986 Sep; 160(3):577-84. PubMed ID: 3526397
    [No Abstract]   [Full Text] [Related]  

  • 19. Current and future directions for clinical investigation of the heart with positron-emission tomography.
    Selwyn AP; Smith TW
    Circulation; 1985 Nov; 72(5 Pt 2):IV31-8. PubMed ID: 3876892
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.